Association Between Serial B-Type Natriuretic Peptide Levels, Vasoactive Drug Weaning, and Adverse Cardiovascular Outcomes in Pediatric Heart Failure.

MLA

Loss, Karla L., et al. “Association Between Serial B-Type Natriuretic Peptide Levels, Vasoactive Drug Weaning, and Adverse Cardiovascular Outcomes in Pediatric Heart Failure.” Journal of the American Heart Association, vol. 13, no. 16, Aug. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1161/JAHA.123.031132.

APA

Loss, K. L., Su, J., Menteer, J., Weisert, M. A., Shaddy, R. E., & Kantor, P. F. (2024). Association Between Serial B-Type Natriuretic Peptide Levels, Vasoactive Drug Weaning, and Adverse Cardiovascular Outcomes in Pediatric Heart Failure. Journal of the American Heart Association, 13(16), 1–11. https://doi.org/10.1161/JAHA.123.031132

Chicago

Loss, Karla L., Jennifer Su, JonDavid Menteer, Molly A. Weisert, Robert E. Shaddy, and Paul F. Kantor. 2024. “Association Between Serial B-Type Natriuretic Peptide Levels, Vasoactive Drug Weaning, and Adverse Cardiovascular Outcomes in Pediatric Heart Failure.” Journal of the American Heart Association 13 (16): 1–11. doi:10.1161/JAHA.123.031132.